These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

476 related items for PubMed ID: 27257840

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Incidence and Risk Factors of the Watershed Shift Phenomenon after Superficial Temporal Artery-Middle Cerebral Artery Anastomosis for Adult Moyamoya Disease.
    Tashiro R, Fujimura M, Kameyama M, Mugikura S, Endo H, Takeuchi Y, Tomata Y, Niizuma K, Tominaga T.
    Cerebrovasc Dis; 2019; 47(3-4):178-187. PubMed ID: 31121577
    [Abstract] [Full Text] [Related]

  • 6. Contralateral acute vascular occlusion following revascularization surgery for moyamoya disease.
    Sussman ES, Madhugiri V, Teo M, Nielsen TH, Furtado SV, Pendharkar AV, Ho AL, Esparza R, Azad TD, Zhang M, Steinberg GK.
    J Neurosurg; 2019 Dec 01; 131(6):1702-1708. PubMed ID: 30554188
    [Abstract] [Full Text] [Related]

  • 7. Perfusion-weighted magnetic resonance imaging used in assessing hemodynamics following superficial temporal artery-middle cerebral artery bypass in patients with Moyamoya disease.
    Li Z, Zhou P, Xiong Z, Ma Z, Wang S, Bian H, Chen J.
    Cerebrovasc Dis; 2013 Dec 01; 35(5):455-60. PubMed ID: 23735877
    [Abstract] [Full Text] [Related]

  • 8. Efficacy assessment of superficial temporal artery-middle cerebral artery bypass surgery in treating moyamoya disease from a hemodynamic perspective: a pilot study using computational modeling and perfusion imaging.
    Wang X, Liu H, Xu M, Chen C, Ma L, Dai F.
    Acta Neurochir (Wien); 2023 Mar 01; 165(3):613-623. PubMed ID: 36595057
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Is local hypoperfusion the reason for transient neurological deficits after STA-MCA bypass for moyamoya disease?
    Mukerji N, Cook DJ, Steinberg GK.
    J Neurosurg; 2015 Jan 01; 122(1):90-4. PubMed ID: 25343178
    [Abstract] [Full Text] [Related]

  • 12. Effects of superficial temporal artery to middle cerebral artery bypass on postoperative infarction rates among young children (≤ 5 years old) with moyamoya disease.
    Takasu S, Kanamori F, Hatano N, Seki Y, Saito R.
    Neurosurg Rev; 2023 Apr 17; 46(1):87. PubMed ID: 37067615
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Outcome in adult patients with hemorrhagic moyamoya disease after combined extracranial-intracranial bypass.
    Jiang H, Ni W, Xu B, Lei Y, Tian Y, Xu F, Gu Y, Mao Y.
    J Neurosurg; 2014 Nov 17; 121(5):1048-55. PubMed ID: 25127415
    [Abstract] [Full Text] [Related]

  • 15. Topographic changes in cerebral blood flow and reduced white matter integrity in the first 2 weeks following revascularization surgery in adult moyamoya disease.
    Kazumata K, Tha KK, Uchino H, Shiga T, Shichinohe H, Ito M, Nakayama N, Abumiya T.
    J Neurosurg; 2017 Aug 17; 127(2):260-269. PubMed ID: 27588593
    [Abstract] [Full Text] [Related]

  • 16. Surgical outcomes following encephaloduroarteriosynangiosis in adult moyamoya disease associated with Type 2 diabetes.
    Ren B, Zhang ZS, Liu WW, Bao XY, Li DS, Han C, Xian P, Zhao F, Wang H, Wang H, Duan L.
    J Neurosurg; 2016 Aug 17; 125(2):308-14. PubMed ID: 26745491
    [Abstract] [Full Text] [Related]

  • 17. Effects of different surgical modalities on the clinical outcome of patients with moyamoya disease: a prospective cohort study.
    Deng X, Gao F, Zhang D, Zhang Y, Wang R, Wang S, Cao Y, Zhao Y, Pan Y, Ye X, Liu X, Zhang Q, Wang J, Yang Z, Zhao M, Zhao J.
    J Neurosurg; 2018 May 17; 128(5):1327-1337. PubMed ID: 28686113
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Surgical outcomes following encephaloduroarteriosynangiosis in North American adults with moyamoya.
    Agarwalla PK, Stapleton CJ, Phillips MT, Walcott BP, Venteicher AS, Ogilvy CS.
    J Neurosurg; 2014 Dec 17; 121(6):1394-400. PubMed ID: 25280094
    [Abstract] [Full Text] [Related]

  • 20. dl-3-n-butylphthalide for alleviation of neurological deficit after combined extracranial-intracranial revascularization for moyamoya disease: a propensity score-matched analysis.
    Li Z, Lu J, Ma L, Wu C, Xu Z, Chen X, Ye X, Wang R, Zhao Y.
    J Neurosurg; 2020 Feb 01; 132(2):421-433. PubMed ID: 30771781
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.